FDAJuly 31, 2026
Maquet Cardiopulmonary Percutaneous Insertion Kit Recall Over Sterile Barrier Integrity
FDA published this notice on July 31, 2026 for Worldwide.
This notice is kept at its address for anyone who saved the link. AreaZine no longer holds the agency's full record for it, so the page shows what AreaZine recorded and links to the agency's own page, the one to read.
What AreaZine recorded
- Agency
- FDA
- Place
- Worldwide
- Date
- July 31, 2026
- Recall class
- Class II
- Reason given by the agency
- The packaging may not consistently maintain sterile barrier integrity.
- Distribution
- Worldwide distribution - US Nationwide and the countries of Australia, Austria, Belarus, Belgium, Brazil, Canada, China, Colombia, Czech Republic, Denmark, Finland, France, Germany, Hong Kong, India, Ireland, Italy, Japan, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Arab Emirates, United Kingdom;
- Official source
- the notice at its source
Official warnings by state, with every type counted since 2008Search notices, places and declaration numbers
Source: FDA.